Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-12.4%
5Y CAGR+8.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-12.4%/yr
vs +104.2%/yr prior
5Y CAGR
+8.6%/yr
Recent deceleration
Acceleration
-116.6pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $32.76M | -32.9% |
| 2024 | $48.85M | -2.1% |
| 2023 | $49.92M | +2.5% |
| 2022 | $48.71M | +6.4% |
| 2021 | $45.78M | +111.6% |
| 2020 | $21.64M | +387.6% |
| 2019 | $4.44M | +58.4% |
| 2018 | $2.80M | - |